Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03% [SIN16938P]

LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03% [SIN16938P]

Active ingredients: LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%

Last updated 26 October 2025

Product Info

LUMIGAN PF (BIMATOPROST OPHTHALMIC SOLUTION) 0.03%

[SIN16938P]

Product information

Active Ingredient and Strength

BIMATOPROST - 0.3 MG/ML

Dosage Form

SOLUTION, STERILE

Manufacturer and Country

ALLERGAN PHARMACEUTICALS IRELAND - IRELAND

Registration Number

SIN16938P

Licence Holder

ABBVIE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

S01EE03

1 INDICATIONS AND USAGE
LUMIGAN® PF 0.03% (bimatoprost ophthalmic solution) is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

2 DOSAGE AND ADMINISTRATION
The recommended dosage is one drop in the affected eye(s) once daily in the evening. LUMIGAN® PF 0.03% (bimatoprost ophthalmic solution) should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the intraocular pressure lowering effect.

Reduction of the intraocular pressure starts approximately 4 hours after the first administration with maximum effect reached within approximately 8 to 12 hours.

LUMIGAN® PF 0.03% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.

4 CONTRAINDICATIONS
LUMIGAN® PF 0.03% is contraindicated in patients with clinically significant hypersensitivity to bimatoprost or to any of the excipients.